Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Science ; 369(6506): 936-942, 2020 08 21.
Article in English | MEDLINE | ID: mdl-32820119

ABSTRACT

Intestinal microbiota have been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated antigens. We identified major histocompatibility complex (MHC) class I-binding epitopes in the tail length tape measure protein (TMP) of a prophage found in the genome of the bacteriophage Enterococcus hirae Mice bearing E. hirae harboring this prophage mounted a TMP-specific H-2Kb-restricted CD8+ T lymphocyte response upon immunotherapy with cyclophosphamide or anti-PD-1 antibodies. Administration of bacterial strains engineered to express the TMP epitope improved immunotherapy in mice. In renal and lung cancer patients, the presence of the enterococcal prophage in stools and expression of a TMP-cross-reactive antigen by tumors correlated with long-term benefit of PD-1 blockade therapy. In melanoma patients, T cell clones recognizing naturally processed cancer antigens that are cross-reactive with microbial peptides were detected.


Subject(s)
Antigens, Neoplasm/immunology , Bacteriophages/immunology , Enterococcus hirae/virology , Gastrointestinal Microbiome/immunology , Histocompatibility Antigens Class I/immunology , Immunotherapy/methods , Neoplasms/therapy , Viral Tail Proteins/immunology , Animals , Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents, Alkylating/therapeutic use , CD8-Positive T-Lymphocytes/immunology , Cross Reactions , Cyclophosphamide/therapeutic use , Epitopes/immunology , Feces/virology , H-2 Antigens/immunology , Humans , Mice , Neoplasms/diet therapy , Neoplasms/immunology , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Programmed Cell Death 1 Receptor/immunology , Viral Tail Proteins/therapeutic use
3.
FEMS Microbiol Rev ; 38(4): 779-801, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24484402

ABSTRACT

Chlamydiae are a group of obligate intracellular bacteria comprising important human and animal pathogens as well as symbionts of ubiquitous protists. They are characterized by a developmental cycle including two main morphologically and physiologically distinct stages, the replicating reticulate body and the infectious nondividing elementary body. In this review, we reconstruct the history of studies that have led to our current perception of chlamydial physiology, focusing on their energy and central carbon metabolism. We then compare the metabolic capabilities of pathogenic and environmental chlamydiae highlighting interspecies variability among the metabolically more flexible environmental strains. We discuss recent findings suggesting that chlamydiae may not live as energy parasites throughout the developmental cycle and that elementary bodies are not metabolically inert but exhibit metabolic activity under appropriate axenic conditions. The observed host-free metabolic activity of elementary bodies may reflect adequate recapitulation of the intracellular environment, but there is evidence that this activity is biologically relevant and required for extracellular survival and maintenance of infectivity. The recent discoveries call for a reconsideration of chlamydial metabolism and future in-depth analyses to better understand how species- and stage-specific differences in chlamydial physiology may affect virulence, tissue tropism, and host adaptation.


Subject(s)
Chlamydia/metabolism , Environmental Microbiology , Animals , Chlamydia Infections/microbiology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...